Enhanced expression of telomerase activity in thymoma and thymic carcinoma tissues: A clinicopathologic study

Cancer

Volumn 94, Issue 1, 2002, Pages 240-244

  Watanabe, Masazumi ^a   Yu, Shan Kang ^a   Sawafuji, Makoto ^a   Kawamura, Masafumi ^a   Horinouchi, Hirohisa ^a   Mukai, Makio ^a   Kobayashi, Koichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Mediastinal tumor; MIC2; Telomerase; Thymic carcinoma; Thymoma

Indexed keywords

ANTIBODY; DNA; GENE PRODUCT; MIC2 ANTIBODY; PROTEIN MIC2; TELOMERASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER STAGING; CELL DIVISION; CHROMOSOME; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TELOMERE; THYMOMA; THYMUS CANCER;

ANTIGENS, CD; CARCINOMA; CELL ADHESION MOLECULES; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; TELOMERASE; THYMOMA; THYMUS NEOPLASMS;

EID: 0036140599     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10194     Document Type: Article

References (16)

1. Specific association of human telomerase activity with immortal cells and cancer
2. High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage
3. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors
4. Follow-up study of thymomas with special reference to their clinical stages
5. Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus
6. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay
7. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer
8. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix
9. Telomerase activity in benign bone tumors and tumor-like lesions
10. Telomerase activity in normal and malignant hematopoietic cells
11. Regulated expression of telomerase activity in human T lymphocyte development and activation
12. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas
13. Constitutive and regulated expression of telomerase reverse transcriptase (hTERT) in human lymphocytes
14. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation
15. Expression of TERT in early premalignant lesions and a subset of cells in normal tissues